Cytek Biosciences, Inc. (CTKB) vs QuidelOrtho Corporation (QDEL)
- Cytek Biosciences, Inc. CTKB 5.82 +7.78%
- QuidelOrtho Corporation QDEL 10.73 −16.43%
Cytek Biosciences, Inc. and QuidelOrtho Corporation are both Medical Devices companies. QuidelOrtho Corporation is the larger, with a market value of $880.5M against $701.9M — 1.3× the size. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against −4.47%. QuidelOrtho Corporation has the higher net margin (−14.2% vs −39.1%) and the higher return on invested capital (−1.75% vs −42.1%). Across the 18 metrics below, QuidelOrtho Corporation leads on 10 and Cytek Biosciences, Inc. on 8.
Valuation
Profitability
| Metric | CTKB | QDEL | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 44.22% | 57.76% |
| Operating margin | (21.13%) | (4.91%) | (14.84%) |
| Net margin | (39.10%) | (14.24%) | (14.45%) |
| Free cash flow margin | (6.43%) | (4.48%) | (5.70%) |
| Return on equity | (23.20%) | (19.29%) | (10.56%) |
| Return on assets | (17.26%) | (6.45%) | (17.26%) |
| Return on invested capital | (42.08%) | (1.75%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack